iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) was the recipient of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 15,622 shares, a decrease of 72.6% from the July 15th total of 57,108 shares. Currently, 0.3% of the shares of the company are short sold. Based on an average daily volume of 28,692 shares, the days-to-cover ratio is currently 0.5 days.
Institutional Trading of iShares Genomics Immunology and Healthcare ETF
An institutional investor recently raised its stake in iShares Genomics Immunology and Healthcare ETF stock. Ameriprise Financial Inc. boosted its holdings in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Free Report) by 8.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 71,473 shares of the company’s stock after buying an additional 5,540 shares during the quarter. Ameriprise Financial Inc. owned approximately 1.42% of iShares Genomics Immunology and Healthcare ETF worth $1,688,000 at the end of the most recent quarter.
iShares Genomics Immunology and Healthcare ETF Stock Performance
Shares of NYSEARCA:IDNA opened at $35.40 on Thursday. The firm has a market cap of $208.86 million, a price-to-earnings ratio of 14.76 and a beta of 0.93. The business has a 50-day simple moving average of $32.38 and a two-hundred day simple moving average of $30.52. iShares Genomics Immunology and Healthcare ETF has a fifty-two week low of $22.11 and a fifty-two week high of $35.51.
About iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
See Also
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- Abercrombie’s Comeback Is a Work in Progress
- Roku’s Ad Business Is Growing—These 3 Stocks Could Be Next
- Cleared for Takeoff: Archer Aviation Changes the Math on eVTOL
- Voyager Technologies: Space Force Deal Fuels Growth Despite Heavy Cash Burn
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
